Business Context and Reporting Period
OrthoPediatrics Corp. (KIDS) filed a Form 8-K on October 9, 2025, reporting preliminary unaudited results for the third quarter ended September 30, 2025. The filing also includes revised financial guidance for the full year ending December 31, 2025, and general business updates.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing specific revenue figures and guidance numbers but does not explicitly state the dollar amounts for revenue, profit, cash flow, margins, debt, or liquidity within the text of this Form 8-K. The filing notes that the preliminary net revenue estimates are subject to audit and may change materially.
Material Changes
The Company has issued revised financial guidance for the fiscal year 2025. No specific quantitative comparison to the prior comparable period is provided in this document text.
Guidance, Outlook, and Risks
- Guidance: Revised full-year 2025 guidance was issued, though specific targets are not detailed in this summary text.
- Unusual Items: The reported Q3 2025 net revenue is preliminary and unaudited.
- Risks and Contingencies: Management cautions that actual results could differ materially from forward-looking statements due to risks outlined in the March 5, 2025, Form 10-K. The Company undertakes no obligation to update these statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue figures and full-year 2025 guidance numbers.
- Verify the final audited Q3 2025 results once the audit process is complete.
- Consult the March 5, 2025, Form 10-K for detailed risk factors affecting the revised outlook.
- Monitor for future filings if the preliminary estimates differ materially from final audited results.